首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   11579篇
  免费   1118篇
  国内免费   195篇
耳鼻咽喉   134篇
儿科学   421篇
妇产科学   250篇
基础医学   883篇
口腔科学   197篇
临床医学   1776篇
内科学   2881篇
皮肤病学   171篇
神经病学   857篇
特种医学   360篇
外科学   2363篇
综合类   119篇
一般理论   9篇
预防医学   970篇
眼科学   505篇
药学   461篇
中国医学   16篇
肿瘤学   519篇
  2023年   143篇
  2022年   74篇
  2021年   194篇
  2020年   163篇
  2019年   144篇
  2018年   265篇
  2017年   291篇
  2016年   312篇
  2015年   315篇
  2014年   416篇
  2013年   631篇
  2012年   440篇
  2011年   535篇
  2010年   496篇
  2009年   543篇
  2008年   508篇
  2007年   482篇
  2006年   484篇
  2005年   474篇
  2004年   397篇
  2003年   396篇
  2002年   356篇
  2001年   169篇
  2000年   126篇
  1999年   205篇
  1998年   259篇
  1997年   255篇
  1996年   348篇
  1995年   310篇
  1994年   238篇
  1993年   167篇
  1992年   156篇
  1991年   179篇
  1990年   107篇
  1989年   158篇
  1988年   129篇
  1987年   114篇
  1986年   120篇
  1985年   119篇
  1984年   137篇
  1983年   112篇
  1982年   112篇
  1981年   106篇
  1980年   120篇
  1978年   94篇
  1977年   72篇
  1976年   62篇
  1975年   72篇
  1972年   62篇
  1964年   59篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
BACKGROUND: Abnormalities in calcium and vitamin D metabolism have been reported after bariatric surgery. The purpose of this study was to evaluate vitamin D nutritional status among morbidly obese patients before gastric bypass surgery. METHODS: We prospectively studied 279 morbidly obese patients seeking gastric bypass surgery for vitamin D nutritional status as assessed by serum 25-hydroxyvitamin D level. In addition, serum samples were analyzed for calcium, alkaline phosphatase (AP), intact parathyroid hormone (PTH), and 1,25-dihydroxyvitamin D. RESULTS: Mean patient age was 43 +/- 9 years; 87% of the study patients were women, and 72% were white. Serum calcium and AP levels were normal in 88% and 89% of the patients, respectively. Vitamin D depletion, defined as serum 25-hydroxyvitamin D level 相似文献   
5.
OBJECTIVES: This study investigates posttraumatic stress disorder (PTSD) and its associated risk factors in a random, national, Canadian sample of United Nations peacekeeping veterans with service-related disabilities. METHODS: Participants included 1016 male veterans (age < 65 years) who served in the Canadian Forces from 1990 to 1999 and were selected from a larger random sample of 1968 veterans who voluntarily and anonymously completed a general health survey conducted by Veterans Affairs Canada in 1999. Survey instruments included the PTSD Checklist-Military Version (PCL-M), Center for Epidemiological Studies-Depression Scale (CES-D), and questionnaires regarding life events during the past year, current stressors, sociodemographic characteristics, and military history. RESULTS: We found that rates of probable PTSD (PCL-M score > 50) among veterans were 10.92% for veterans deployed once and 14.84% for those deployed more than once. The rates of probable clinical depression (CES-D score > 16) were 30.35% for veterans deployed once and 32.62% for those deployed more than once. We found that, in multivariate analyses, probable PTSD rates and PTSD severity were associated with younger age, single marital status, and deployment frequency. CONCLUSIONS: PTSD is an important health concern in the veteran population. Understanding such risk factors as younger age and unmarried status can help predict morbidity among trauma-exposed veterans.  相似文献   
6.
On the Bubble     
Thompson  Don 《JAMA》2006,296(14):1698
  相似文献   
7.
8.
9.
Summary Cytosine arabinsodie (ara-C) and etoposide (VP-16) display synergy in the laboratory. Twenty-six patients participated in a phase I study of high-dose ara-C in combination with VP-16. The dose of VP-16 was held constant at 50 mg/m2 as an intermittent infusion over 33 h; escalating doses of ara-C were given as infusions during hours 9–12 and 21–24. Myelosuppression was the dose-limiting toxicity and occurred with doses considerably less than those expected from studies of the two drugs as single agents. The suggested initial doses for phase II trials with this schedule are 750 mg/m2×2 doses of ara-C and 50 mg/m2 of VP-16. Nonhematologic toxicity was minimal; therefore, further dose escalation is feasible in patients in whom myelosuppression is acceptable.Supported in part by grants from the National Cancer Institute (CA-12197 and CA-09422) and the American Cancer Society CF-85-182  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号